Related Experiment Video

Updated: Dec 13, 2025

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)
07:01

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)

Published on: February 7, 2025

766

Pediatric Headache Management and Use of the PedMIDAS

Rachel D Livingston1, Debra Shockey1, Lawrence Morton1

  • 1Virginia Commonwealth University, Richmond, Virginia.

Journal of Doctoral Nursing Practice
|August 4, 2020
PubMed

Insights

The Pediatric Migraine Disability Assessment tool (PedMIDAS) helps quantify childhood headache disability, though its use was limited. Providers found PedMIDAS valuable for assessing pediatric headache patients.

Area of Science:

  • Pediatric Neurology
  • Quality Improvement
  • Pain Assessment

Background:

  • Childhood headache significantly impacts quality of life and necessitates frequent medical attention.
  • The Pediatric Migraine Disability Assessment tool (PedMIDAS) is a validated instrument for assessing pediatric headache.
  • The American Academy of Neurology supports PedMIDAS use in headache management guidelines.

Purpose of the Study:

  • To implement the PedMIDAS in a pediatric neurology practice to standardize care for pediatric headache patients.
  • To evaluate provider satisfaction with the use of the PedMIDAS.

Main Methods:

  • A quality improvement project involving chart review from November 21, 2016, to November 30, 2017.
  • Provider and staff education on the administration and utility of the PedMIDAS preceded the chart review period.

Main Results:

  • The PedMIDAS was utilized in 23% of pediatric headache patient encounters (404 out of 1741).

Conclusions:

  • Despite suboptimal adherence, surveyed providers reported the PedMIDAS as a useful tool for quantifying disability in pediatric headache patients.
  • Implementing the PedMIDAS aids in evaluating headache interventions, distinguishing headache frequency from disability, and clarifying the impact of pain on daily life.
Abstract

Keywords:
PedMIDASinterventionspatient carepediatric headachequestionnaire usefulness

More Related Videos

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure15:18

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure

Published on: July 30, 2009

18.5K
A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

30.9K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
131
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
153
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
111
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
175
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
147
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.3K